Breast cancer interventional device firm SenoRx will offer 5.5 million shares of its common stock in an initial public offering (IPO) at a price of $8 per share.
The Aliso Viejo, CA-based SenoRx said it has granted the underwriters an option to purchase up to an additional 825,000 shares at the IPO price to cover overallotments, if any. The common stock will trade on the Nasdaq Global Market under the symbol "SENO."
By AuntMinnie.com staff writers
March 30, 2007
Related Reading
Road to RSNA, SenoRx, November 9, 2006
Suros and SenoRx to bury patent hatchet, May 25, 2006
SenoRx adds new probe, February 23, 2006
SenoRx lands patent for partial-breast radiation balloon, January 17, 2006
Suros sues SenoRx, February 28, 2005
Copyright © 2007 AuntMinnie.com
